Spanish Generic Medicines Association

Who is AESEG

AESEG is the official representative body of the generic pharmaceutical industry in Spain

Generic Medicines Definitions

A generic medicine has the same composition and the same pharmaceutical form as an original medicine

Generics in Spain

Generic medicines in Spain are still far away from the European average

Studies and Reports about Generics Medicines

Studies and Reports about Generics Medicines

Upcoming Events

10th Pharmacovigilance Conference

10TH PHARMACO-VIGILANCE CONFERENCE

LONDON, 25 JANUARY 2017

Read More
16th Regulatory and Scientific Affairs Conference

16TH REGULATORY AND SCIENTIFIC AFFAIRS CONFERENCE

LONDON, 26-27 JANUARY 2017

Read More
13th Legal Affairs Conference

13TH LEGAL AFFAIRS CONFERENCE

LONDON, 22-23 MARCH 2017

Read More
15th Biosimilar Medicines Conference

15TH BIOSIMILAR MEDICINES CONFERENCE

23-24 MARCH 2017

Read More

 

EN GENERICO MAGAZINE Nº 22

Access to medicines

This December marks the 20th anniversary of the creation and regulation of generic pharmaceutical specialties (EFG) in Spain. The approval of Law 13/1996 of December 30 about Fiscal, Administrative and Social Order Measures, which included several aspects in relation to generic medicines; Among others, its definition and the form of its denomination, meant a before and after in the access of patients to the treatments and in the sustainability of our National Health System.

Read More

 

EN GENERICO MAGAZINE Nº 22 - Access to medicines

En generico Blog 

For your health, for the health of all of us

Blog aimed at anyone who wants to express opinions through comments, suggestions and articles of collaborations.
We offer everyone, this place to spread more rigorous knowledge of the generic medicines in the Spanish society.


Read more

Medicines for Europe: vision

Patients

We create enhanced access to medicines, reducing inequalities, directly leading to improved patient outcomes. We compete, stimulating the medicines industry to innovate. We innovate, enriching patient benefit.

 

Quality

We provide a stable and resilient supply of high-quality medicines, manufactured and developed according to stringent EU regulatory requirements, for Europe’s patients and healthcare providers.

Value

Our high-quality cost-effective medicines account for well over 54% of all prescription medicines used to treat European patients. We are the heart of public health delivery in Europe. We generate cost savings of more than €35bn each year ensuring the viability of Europe’s healthcare systems and enable them to invest in new medicines and other treatments that Europe’s patients increasingly need.

Sustainability

Use of our medicines supports the economic sustainability of Europe’s healthcare systems. We contribute to Europe’s economies, researching, developing and manufacturing in most European countries the majority of medicines used in the EU, sustaining more than 150.000 high skilled, high value direct jobs. As a leading knowledge based industry we will continue to work with Europe’s policy makers, legislators and regulators to create the right environment to support and strengthen the economic sustainability of our industry so that we can continue to contribute to European patients and society.

Partnership

We build constructive partnerships, focused on a strong and stable collaboration with patients and patient organisations, the EU institutions, governments and regulators, healthcare professionals and others to further enhance public health in Europe.

Medicines for Europe

Search


@AESEG_genericos

AESEG_genericos Tres ideas para una farmacia diferente: Premios a la Innovación en la Farmacia Comunitaria de @CinfaSalud ow.ly/mbbI30amS0S

7 hours ago. via Hootsuite

AESEG_genericos Sistema español de verificación de medicamentos: previsiones para 2019 ow.ly/uTQp30amIej

8 hours ago. via Hootsuite

Flickr AESEG